@Lintin Very valid points. Echo is the only company to come closest to developing a noninvasive glucose device. If the Apple Watch will be void of "groundbreaking" technology, why not make a play for Echo's IP and parents? Apple certainly has the resources to develop ECTE's TCGM for the entire spectrum of glucose populations - critical care to outpatient to fitness.
It seems like a waste of the shareholders money to allow Echo's of technology and $100 of millions of R&D to dies on the vine.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.